The Global Mycoplasma Testing Market is expected to witness a high growth rate of 11% from 2022 to 2027. Growing R&D ...

The aldosterone-renin screening market is forecasted to grow from USD 574.8 million in 2025 to USD 1,109.7 million by 2035, at a CAGR of 6.8% during the forecast period. The aldosterone-renin ...

The 12th edition of the European Pharmacopoeia will be an all-digital, redesigned, user-friendly issue.

The company plans to bring to market in the coming years a series of microarray-based tests for autoimmune diseases and allergies, among other tests.

The growing incidence of infectious diseases, cancer, and chronic illnesses has substantially increased the demand for ...